These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 10762579)

  • 1. Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults.
    Boivin G; Goyette N; Hardy I; Aoki F; Wagner A; Trottier S
    J Infect Dis; 2000 Apr; 181(4):1471-4. PubMed ID: 10762579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
    Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K
    N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
    Mäkelä MJ; Pauksens K; Rostila T; Fleming DM; Man CY; Keene ON; Webster A
    J Infect; 2000 Jan; 40(1):42-8. PubMed ID: 10762110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.
    Matsumoto K; Ogawa N; Nerome K; Numazaki Y; Kawakami Y; Shirato K; Arakawa M; Kudoh S; Shimokata K; Nakajima S; Yamakido M; Kashiwagi S; Nagatake T
    Antivir Ther; 1999; 4(2):61-8. PubMed ID: 10682150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [symbol: see text] Zanamivir for influenza.
    Drug Ther Bull; 1999 Nov; 37(11):81-4. PubMed ID: 10696691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
    Hayden FG; Gubareva LV; Monto AS; Klein TC; Elliot MJ; Hammond JM; Sharp SJ; Ossi MJ;
    N Engl J Med; 2000 Nov; 343(18):1282-9. PubMed ID: 11058672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.
    Lancet; 1998 Dec; 352(9144):1877-81. PubMed ID: 9863784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of inhaled zanamivir in the treatment and prevention of influenza].
    Abad-Santos F; Gallego Sandín S; Novalbos Reina J; Martínez Sancho E; Gálvez Múgica MA
    An Med Interna; 2001 Feb; 18(2):93-9. PubMed ID: 11322008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New diagnostic possibilities and medications. Fit for influenza?].
    Wutzler P
    MMW Fortschr Med; 2002 Nov; 144(48):18. PubMed ID: 12532540
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
    Vogel GE
    Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.
    Höffken G; Gillissen A
    Med Microbiol Immunol; 2002 Dec; 191(3-4):169-73. PubMed ID: 12458354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating influenza with zanamivir.
    Read RC
    Lancet; 1998 Dec; 352(9144):1872-3. PubMed ID: 9863779
    [No Abstract]   [Full Text] [Related]  

  • 14. Zanamivir: from drug design to the clinic.
    Elliott M
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1885-93. PubMed ID: 11779388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zanamivir: an influenza virus neuraminidase inhibitor.
    Colman PM
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):191-9. PubMed ID: 15918777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study.
    Kaiser L; Henry D; Flack NP; Keene O; Hayden FG
    Clin Infect Dis; 2000 Mar; 30(3):587-9. PubMed ID: 10722450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.
    Monto AS; Fleming DM; Henry D; de Groot R; Makela M; Klein T; Elliott M; Keene ON; Man CY
    J Infect Dis; 1999 Aug; 180(2):254-61. PubMed ID: 10395837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM; Gunawardena KA; Macmahon MM; Bye A
    Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated treatment for influenza A and B.
    Montalto NJ; Gum KD; Ashley JV
    Am Fam Physician; 2000 Dec; 62(11):2467-76. PubMed ID: 11130232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuraminidase inhibitors slightly beneficial for shortening flu symptoms.
    Phillips TG
    J Fam Pract; 2003 Oct; 52(10):747-8. PubMed ID: 14529590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.